Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (3)
- (-) Bioenergy (2)
- (-) Computer Science (11)
- (-) Frontier (5)
- (-) Materials Science (2)
- (-) Neutron Science (1)
- 3-D Printing/Advanced Manufacturing (1)
- Biomedical (1)
- Cybersecurity (4)
- Energy Storage (1)
- Exascale Computing (1)
- Grid (1)
- High-Performance Computing (2)
- Machine Learning (1)
- Microscopy (1)
- National Security (1)
- Physics (1)
- Quantum Computing (3)
- Quantum Science (4)
- Security (1)
- Summit (6)
- Sustainable Energy (2)
Media Contacts
Using the Titan supercomputer and the Spallation Neutron Source at the Department of Energy’s Oak Ridge National Laboratory, scientists have created the most accurate 3D model yet of an intrinsically disordered protein, revealing the ensemble of its atomic-level structures.
Processes like manufacturing aircraft parts, analyzing data from doctors’ notes and identifying national security threats may seem unrelated, but at the U.S. Department of Energy’s Oak Ridge National Laboratory, artificial intelligence is improving all of these tasks.
A team of scientists led by Oak Ridge National Laboratory have discovered the specific gene that controls an important symbiotic relationship between plants and soil fungi, and successfully facilitated the symbiosis in a plant that
OAK RIDGE, Tenn., May 7, 2019—The U.S. Department of Energy today announced a contract with Cray Inc. to build the Frontier supercomputer at Oak Ridge National Laboratory, which is anticipated to debut in 2021 as the world’s most powerful computer with a performance of greater than 1.5 exaflops.
OAK RIDGE, Tenn., May 7, 2019—Energy Secretary Rick Perry, Congressman Chuck Fleischmann and lab officials today broke ground on a multipurpose research facility that will provide state-of-the-art laboratory space
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.